| Consensus guidelines for the detection of immunogenic cell death O Kepp, L Senovilla, I Vitale, E Vacchelli, S Adjemian, P Agostinis, ... Oncoimmunology 3 (9), e955691, 2014 | 886 | 2014 |
| Classification of current anticancer immunotherapies L Galluzzi, E Vacchelli, JM Bravo-San Pedro, A Buqué, L Senovilla, ... Oncotarget 5 (24), 12472, 2014 | 586 | 2014 |
| Caloric restriction mimetics enhance anticancer immunosurveillance F Pietrocola, J Pol, E Vacchelli, S Rao, DP Enot, EE Baracco, S Levesque, ... Cancer cell 30 (1), 147-160, 2016 | 544 | 2016 |
| Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy J Pol, E Vacchelli, F Aranda, F Castoldi, A Eggermont, I Cremer, ... Oncoimmunology 4 (4), e1008866, 2015 | 319 | 2015 |
| Trial watch: IDO inhibitors in cancer therapy E Vacchelli, F Aranda, A Eggermont, C Sautes-Fridman, E Tartour, ... Oncoimmunology 3 (10), e957994, 2014 | 251 | 2014 |
| Trial Watch: Chemotherapy with immunogenic cell death inducers E Vacchelli, F Aranda, A Eggermont, J Galon, C Sautès-Fridman, I Cremer, ... Oncoimmunology 3 (3), e27878, 2014 | 185 | 2014 |
| Trial Watch: Peptide vaccines in cancer therapy F Aranda, E Vacchelli, A Eggermont, J Galon, C Sautes-Fridman, ... Oncoimmunology 2 (12), e26621, 2013 | 154 | 2013 |
| Trial Watch—Oncolytic viruses and cancer therapy J Pol, A Buqué, F Aranda, N Bloy, I Cremer, A Eggermont, P Erbs, ... Oncoimmunology 5 (2), e1117740, 2016 | 144 | 2016 |
| Trial Watch: Immunostimulatory monoclonal antibodies in cancer therapy F Aranda, E Vacchelli, A Eggermont, J Galon, WH Fridman, L Zitvogel, ... Oncoimmunology 3 (2), e27297, 2014 | 136 | 2014 |
| Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications A Buqué, N Bloy, F Aranda, F Castoldi, A Eggermont, I Cremer, ... Oncoimmunology 4 (4), e1008814, 2015 | 119 | 2015 |
| Trial Watch: Tumor-targeting monoclonal antibodies in cancer therapy E Vacchelli, F Aranda, A Eggermont, J Galon, C Sautes-Fridman, ... Oncoimmunology 3 (1), e27048, 2014 | 112 | 2014 |
| Acyl-CoA-binding protein is a lipogenic factor that triggers food intake and obesity JM Bravo-San Pedro, V Sica, I Martins, J Pol, F Loos, MC Maiuri, ... Cell Metabolism 30 (4), 754-767. e9, 2019 | 110 | 2019 |
| Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer A Buqué, N Bloy, M Perez-Lanzón, K Iribarren, J Humeau, JG Pol, ... Nature Communications 11 (1), 3819, 2020 | 102 | 2020 |
| CD6 modulates thymocyte selection and peripheral T cell homeostasis M Orta-Mascaró, M Consuegra-Fernández, E Carreras, R Roncagalli, ... Journal of experimental medicine 213 (8), 1387-1397, 2016 | 95 | 2016 |
| Immune-dependent antineoplastic effects of cisplatin plus pyridoxine in non-small-cell lung cancer F Aranda, N Bloy, J Pesquet, B Petit, K Chaba, A Sauvat, O Kepp, ... Oncogene 34 (23), 3053-3062, 2015 | 87 | 2015 |
| Trial Watch: Toll-like receptor agonists in oncological indications F Aranda, E Vacchelli, F Obrist, A Eggermont, J Galon, C Sautès-Fridman, ... Oncoimmunology 3 (6), e29179, 2014 | 87 | 2014 |
| Novel strategies exploiting interleukin-12 in cancer immunotherapy A Cirella, C Luri-Rey, CA Di Trani, A Teijeira, I Olivera, E Bolaños, ... Pharmacology & therapeutics 239, 108189, 2022 | 86 | 2022 |
| Trial watch: dendritic cell-based anticancer therapy N Bloy, J Pol, F Aranda, A Eggermont, I Cremer, WH Fridman, J Fučíková, ... Oncoimmunology 3 (11), e963424, 2014 | 86 | 2014 |
| Adjuvant combination and antigen targeting as a strategy to induce polyfunctional and high-avidity T-cell responses against poorly immunogenic tumors F Aranda, D Llopiz, N Díaz-Valdés, JI Riezu-Boj, J Bezunartea, M Ruiz, ... Cancer research 71 (9), 3214-3224, 2011 | 85 | 2011 |
| Induction of monocyte chemoattractant protein-1 and interleukin-10 by TGFβ1 in melanoma enhances tumor infiltration and immunosuppression N Díaz-Valdés, M Basagoiti, J Dotor, F Aranda, I Monreal, JI Riezu-Boj, ... Cancer research 71 (3), 812-821, 2011 | 85 | 2011 |
Guido KroemerUniversité de Paris Cité, Hôpital Européen George Pompidou - AP-HP, Gustave Roussy Cancer CampusEmail được xác minh tại inserm.fr